Diagnostic delay, comorbid hidradenitis suppurativa and the prognostic value of bacterial culture in folliculitis decalvans: A cohort study

J Dtsch Dermatol Ges. 2023 Dec;21(12):1469-1477. doi: 10.1111/ddg.15202. Epub 2023 Oct 24.

Abstract

Background: Folliculitis decalvans (FD) is a type of primary neutrophilic cicatricial alopecia often leading to irreversible hair loss. Data on its epidemiology, clinical features, outcomes, and prognostic factors are limited.

Objective: To evaluate a cohort of patients with FD and identify characteristics of severe disease and prognostic factors which impede remission.

Patients and methods: This retrospective cohort study included 192 patients diagnosed with FD and followed for at least six months at a tertiary center between 2010 and 2020.

Results: There was a diagnostic delay averaging 22.2 (± 29.7) months. Comorbid follicular occlusion disorders were common. Bacterial cultures were positive in 45.6% of the cases, with Staphylococcus (S.) aureus being the most common pathogen. Severe disease was associated with comorbid hidradenitis suppurativa and a positive bacterial culture, particularly S. aureus. 50.7% of patients experienced complete remission: 32% within the first six months of treatment and 18.7% later during follow-up. Relapses were frequent. Negative prognostic factors for achieving remission included younger age and a positive bacterial culture.

Conclusions: There is a need for the education of dermatologists to reduce the diagnostic delay. Screening FD patients for comorbid hidradenitis suppurativa and obtaining bacterial cultures is important for treatment planning.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alopecia / diagnosis
  • Alopecia / drug therapy
  • Alopecia / epidemiology
  • Cohort Studies
  • Delayed Diagnosis
  • Folliculitis* / diagnosis
  • Folliculitis* / drug therapy
  • Folliculitis* / epidemiology
  • Hidradenitis Suppurativa* / complications
  • Hidradenitis Suppurativa* / diagnosis
  • Hidradenitis Suppurativa* / epidemiology
  • Humans
  • Prognosis
  • Retrospective Studies
  • Staphylococcus aureus